Cargando…
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
Autores principales: | Schaule, Jana, Kroeze, Stephanie G. C., Blanck, Oliver, Stera, Susanne, Kahl, Klaus H., Roeder, Falk, Combs, Stephanie E., Kaul, David, Claes, An, Schymalla, Markus M., Adebahr, Sonja, Eckert, Franziska, Lohaus, Fabian, Abbasi-Senger, Nasrin, Henke, Guido, Szuecs, Marcella, Geier, Michael, Sundahl, Nora, Buergy, Daniel, Dummer, Reinhard, Guckenberger, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734768/ https://www.ncbi.nlm.nih.gov/pubmed/33317582 http://dx.doi.org/10.1186/s13014-020-01708-y |
Ejemplares similares
-
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score
por: Schaule, Jana, et al.
Publicado: (2020) -
Continued versus Interrupted Targeted Therapy during Metastasis-Directed Stereotactic Radiotherapy: A Retrospective Multi-Center Safety and Efficacy Analysis
por: Kroeze, Stephanie G. C., et al.
Publicado: (2021) -
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database
por: Kroeze, Stephanie G. C., et al.
Publicado: (2021) -
Toxicity of combined targeted therapy and concurrent radiotherapy in metastatic melanoma patients: a single-center retrospective analysis
por: Ziegler, Johanna S., et al.
Publicado: (2020) -
MRI characteristics in treatment for cerebral melanoma metastasis using stereotactic radiosurgery and concomitant checkpoint inhibitors or targeted therapeutics
por: Rauch, Maximilian, et al.
Publicado: (2021)